KindlyMD Announces Second Quarter 2024 Financial Results and Provides Shareholder Update
KindlyMD Announces Second Quarter 2024 Financial Results and Provides Shareholder Update
Company provides nearly 80% statewide comprehensive insurance coverage in Utah under contract with providers such as Medicare, Select Health, Medicaid, and Blue Cross Blue Shield
根據與醫療保險、精選健康、醫療補助和藍十字藍盾等提供商簽訂的合同,公司在猶他州提供近80%的全州綜合保險
Reimbursement from insurance payors increased 163.7% sequentially and is expected to increase as a percentage of total revenue going forward
保險支付人的報銷額連續增長了163.7%,預計未來佔總收入的百分比將增加
Reimbursements from insurance payors totaled $126,325 in first half of 2024 as compared to $0 during the first half of 2023
2024年上半年,保險支付人的報銷總額爲126,325美元,而2023年上半年爲0美元
SALT LAKE CITY, UT / ACCESSWIRE / August 14, 2024 / KindlyMD, Inc. ("KindlyMD" or the "Company") (NASDAQ:KDLY), a patient-first healthcare and healthcare data company uniquely integrating traditional primary care and pain management strategies with integrated behavioral and alternative therapies, today announced its financial results for the second quarter ended June 30, 2024 and is providing a shareholder update.
猶他州鹽湖城/ACCESSWIRE/2024年8月14日/KindlyMD, Inc.(「KindlyMD」 或 「公司」)(納斯達克股票代碼:KDLY)是一家以患者爲先的醫療保健和醫療保健數據公司,將傳統的初級保健和疼痛管理策略與綜合行爲和替代療法獨特地整合在一起,今天公佈了截至2024年6月30日的第二季度財務業績,並提供了股東最新情況。
Tim Pickett, PA-C, KindlyMD Founder and CEO, stated, "During the second quarter we successfully closed on our IPO for gross proceeds of approximately $6 million. While from a total revenue perspective during the quarter we did not yet yield the return on investment from the additional working capital we received, we are very pleased with the 163.7% sequential growth in reimbursement from insurance payors. As Utah's first alternative medical treatment company to contract under the state's top insurance payors, we are laser focused on growing this segment of our revenue stream. We are now proud to provide nearly 80% of statewide comprehensive insurance coverage to the Utah community, through top providers including Medicare, Select Health, Medicaid, and Blue Cross Blue Shield, according to the 2023 Utah Health Insurance Market Report. We are working to continue this growth trend, particularly as we invest in the acquisition of new patients to our facilities."
KindlyMD創始人兼首席執行官PA-C蒂姆·皮克特表示:「在第二季度,我們成功完成了首次公開募股,總收益約爲600萬美元。儘管從總收入的角度來看,我們在本季度尚未從收到的額外營運資金中獲得投資回報,但我們對保險支付人報銷額連續增長163.7%感到非常滿意。作爲猶他州第一家與該州最高保險支付方簽訂合同的替代醫療公司,我們專注於發展收入來源的這一部分。根據2023年猶他州健康保險市場報告,我們現在很自豪能夠通過包括醫療保險、精選健康、醫療補助和藍十字藍盾在內的頂級提供商向猶他州社區提供近80%的全州綜合保險。我們正在努力延續這一增長趨勢,尤其是在我們投資爲我們的設施招收新患者時。」
"Our team is also focused on aggressive growth via accretive acquisitions of clinics in Utah to expand our footprint. As a leader in the market, we see significant opportunity to potentially acquire profitable locations and integrate onto our platform driving operational synergies and margin expansion. The market is highly fragmented, and our potential pipeline remains robust. We look forward to updating our shareholders on our progress in the near future."
「我們的團隊還專注於通過增值收購猶他州的診所來實現積極增長,以擴大我們的足跡。作爲市場領導者,我們看到了巨大的機會,可以收購盈利的地點並整合到我們的平台上,從而推動運營協同效應和利潤擴大。市場高度分散,我們的潛在渠道仍然強勁。我們期待在不久的將來向股東通報我們的最新進展。」
Operational Highlights:
運營亮點:
Completed IPO in June 2024 for net proceeds of $6.02 million
Achieved nearly 80% statewide comprehensive insurance coverage in Utah according to the 2023 Utah Health Insurance Market Report
Became Utah's first alternative medical treatment company to contract under the state's top insurance payors, which now include Medicare, Select Health and Medicaid and Blue Cross Blue Shield
Collaborated with Curaleaf to expand patient education on medical cannabis care in Utah with community care events held at multiple Curaleaf Utah medical cannabis pharmacies
Successfully registered on SAM.gov, the official U.S. federal funding platform
2024 年 6 月完成首次公開募股,淨收益爲 602 萬美元
根據2023年猶他州健康保險市場報告,猶他州實現了近80%的全州綜合保險覆蓋率
成爲猶他州第一家與該州最高保險支付方簽訂合同的替代醫療公司,這些支付方現在包括醫療保險、精選健康和醫療補助以及藍十字藍盾
與Curaleaf合作,在猶他州Curaleaf的多家醫用大麻藥房舉辦社區護理活動,擴大猶他州患者對醫用大麻護理的教育
在美國官方聯邦資助平台 SAM.gov 上成功註冊
Subsequent Events:
後續事件:
Submitted a comment to the U.S. Department of Justice, following its recent proposed rule to reclassify cannabis from Schedule I to Schedule III of the Controlled Substances Act
在美國司法部最近提出將大麻從《管制物質法》附表一改爲附表三的規則之後,向美國司法部提交了評論意見
Financial Highlights for the Quarterly Period Ended June 30, 2024
截至2024年6月30日的季度財務摘要
The Company earned $91,553 in reimbursements from insurance payors during the three months ending June 30, 2024, an increase of 163.7% over the $34,722 earned for the three months ending March 31, 2024. The Company earned $126,325 in reimbursements from insurance payors during the six months ended June 30, 2024, as compared to $0 during the three and six months ended June 30, 2023.
在截至2024年6月30日的三個月中,公司從保險支付人那裏獲得了91,553美元的報銷,比截至2024年3月31日的三個月的34,722美元增長了163.7%。在截至2024年6月30日的六個月中,公司從保險支付人那裏獲得了126,325美元的報銷,而在截至2023年6月30日的三個月和六個月中,該報銷額爲0美元。
Revenues decreased by $340,481, or 34.8%, to $639,057 for the three months ended June 30, 2024, from $979,538 for the three months ended June 30, 2023. The decrease in revenues is primarily attributed to a decrease in cash-pay patient care services as KindlyMD continues to shift toward insurance billing with commercial and governmental payers including Medicare, Medicaid, Select Health, Blue Cross Blue Shield, and other commercial payers compared to the prior period.
截至2024年6月30日的三個月,收入從截至2023年6月30日的三個月的979,538美元下降了340,481美元,至639,057美元,跌幅34.8%。收入下降的主要原因是與前一時期相比,KindlyMD繼續轉向由包括Medicare、Medicaid、Select Health、藍十字藍盾和其他商業付款人在內的商業和政府付款人的保險賬單,現金支付的患者護理服務減少。
Operating expenses increased by $95,423, or 6.0%, to $1,676,250 for the three months ended June 30, 2024, from $1,580,827 for the three months ended June 30, 2023. The increase in operating expenses is primarily attributable to an increase in general and administrative expenses, salaries and wages, and cost of revenues.
截至2024年6月30日的三個月,運營費用從截至2023年6月30日的三個月的1,580,827美元增加了95,423美元,增幅6.0%,至1,676,250美元。運營費用的增加主要歸因於一般和管理費用、薪金和工資以及收入成本的增加。
Net loss per share decreased by $0.13, or 100.0%, to $(0.26) for the three months ended June 30, 2024, compared to $(0.13) for the three months ended June 30, 2023. KindlyMD management strives to look for opportunities to optimize revenue by increasing sales, acquiring additional clinics, improving margins, and controlling ongoing operating expenses.
截至2024年6月30日的三個月,每股淨虧損下降了0.13美元,至0.26美元,跌幅100.0%,而截至2023年6月30日的三個月,每股淨虧損爲0.13美元(0.13美元)。KindlyMD 管理層努力通過增加銷售額、收購更多診所、提高利潤率和控制持續運營支出來尋找優化收入的機會。
As of June 30, 2024, the Company had cash and cash equivalents of $4.74 million and total working capital of $4.11 million.
截至2024年6月30日,該公司的現金及現金等價物爲474萬美元,營運資金總額爲411萬美元。
In June 2024, KindlyMD completed its IPO for total net proceeds of $6.02 million, providing adequate liquidity and cash reserves to meet its obligations for at least the 12-month period following June 30, 2024, and to assist the Company in implementing its strategic operational business plans to create sustained cash flow generation thereafter.
2024年6月,KindlyMD完成了首次公開募股,總淨收益爲602萬美元,提供了充足的流動性和現金儲備,以履行其在2024年6月30日之後的至少12個月期間的債務,並協助公司實施其戰略運營業務計劃,以創造持續的現金流。
As of August 9, 2024, the Company had 5,947,169 common shares outstanding.
截至2024年8月9日,該公司的已發行普通股爲5,947,169股。
About KindlyMD
關於 KindlyMD
KindlyMD is a patient-first healthcare and healthcare data company uniquely integrating traditional primary care and pain management strategies with integrated behavioral and alternative therapies to offer patients comprehensive care and reduce the addiction and dependency of opioid use in the U.S. KindlyMD currently operates four centers, including the largest alternative pain treatment center in Utah. With a focus on holistic pain management through its specialty outpatient clinical services, including, where appropriate, the recommendation of medical cannabis by KindlyMD healthcare providers, KindlyMD is providing better patient health outcomes.
KindlyMD 是一家以患者爲先的醫療保健和醫療保健數據公司,獨特地將傳統的初級保健和疼痛管理策略與綜合行爲和替代療法相結合,爲患者提供全面護理,減少美國阿片類藥物使用的成癮和依賴。KindlyMD 目前運營四個中心,包括猶他州最大的替代性疼痛治療中心。KindlyMD 專注於通過其專業門診臨床服務(酌情包括 KindlyMD 醫療保健提供者推薦的醫用大麻)進行全面的疼痛管理,爲患者提供更好的健康結果。
For more information, please visit .
欲了解更多信息,請訪問。
Forward-Looking Statements
前瞻性陳述
This press release contains certain forward-looking statements that are based upon current expectations and involve certain risks and uncertainties within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Such forward-looking statements can be identified by the use of words such as "should," "may," "intends," "anticipates," "believes," "estimates," "projects," "forecasts," "expects," "plans," and "proposes." These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties, and other factors, some of which are beyond our control and difficult to predict and could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements. You are urged to carefully review and consider any cautionary statements and other disclosures, including the statements made under the heading "Risk Factors" in KindlyMD, Inc.'s Annual Report on Form 10-K for the fiscal year ended December 31, 2022. KindlyMD, Inc. does not undertake any duty to update any forward-looking statements except as may be required by law. The information which appears on our websites and our social media platforms, including, but not limited to, Instagram and Facebook, is not part of this press release.
本新聞稿包含某些前瞻性陳述,這些陳述基於當前預期,涉及1995年《美國私人證券訴訟改革法》所指的某些風險和不確定性。此類前瞻性陳述可以通過使用 「應該」、「可能」、「打算」、「預期」、「相信」、「估計」、「項目」、「預測」、「期望」、「計劃」 和 「提議」 等詞語來識別。這些前瞻性陳述不能保證未來的表現,並受風險、不確定性和其他因素的影響,其中一些因素是我們無法控制的,難以預測,可能導致實際結果與前瞻性陳述中表達或預測的結果存在重大差異。我們敦促您仔細審查和考慮任何警示聲明和其他披露,包括在 KindlyMD, Inc. 「風險因素」 標題下發表的聲明。”截至2022年12月31日的財政年度的10-K表年度報告。除非法律要求,否則KindlyMD, Inc.不承擔任何更新任何前瞻性陳述的責任。出現在我們的網站和社交媒體平台(包括但不限於Instagram和Facebook)上的信息不在本新聞稿中。
Investor Relations Contact:
投資者關係聯繫人:
Valter Pinto, Managing Director
KCSA Strategic Communications
(212) 896-1254
KindlyMD@KCSA.com
瓦爾特·平託,董事總經理
KCSA 戰略傳播
(212) 896-1254
KindlyMD@KCSA.com
KINDLY MD, INC.
CONDENSED BALANCE SHEETS
謝謝 MD, INC.
簡明的資產負債表
June 30, 2024 |
December 31, 2023 |
|||||||
(Unaudited) |
||||||||
ASSETS |
||||||||
Current Assets |
||||||||
Cash and cash equivalents |
$ |
4,740,006 |
$ |
525,500 |
||||
Accounts receivable |
5,182 |
28,001 |
||||||
Inventories, net |
3,825 |
63,202 |
||||||
Prepaid expenses and other current assets |
305,655 |
225 |
||||||
Total Current Assets |
5,054,668 |
616,928 |
||||||
Property and equipment, net |
206,816 |
235,292 |
||||||
Operating lease right-of-use assets |
184,177 |
235,706 |
||||||
Security deposits |
11,276 |
11,276 |
||||||
TOTAL ASSETS |
$ |
5,456,937 |
$ |
1,099,202 |
||||
LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT) |
||||||||
Current Liabilities |
||||||||
Accounts payable and accrued expenses |
$ |
628,749 |
$ |
329,810 |
||||
Customer deposits |
4,150 |
3,425 |
||||||
Current portion of operating lease liabilities |
79,973 |
94,696 |
||||||
Current portion of finance lease liabilities |
2,010 |
- |
||||||
Current portion of notes payable, net |
228,061 |
148,517 |
||||||
Derivative liability |
- |
238,000 |
||||||
Total Current Liabilities |
942,943 |
814,448 |
||||||
Operating lease liabilities, net of current portion |
124,651 |
164,295 |
||||||
Finance lease liabilities, net of current portion |
8,635 |
|||||||
Notes payable, net of current portion |
- |
228,871 |
||||||
TOTAL LIABILITIES |
1,076,229 |
1,207,614 |
||||||
Stockholders' Equity (Deficit) |
||||||||
Preferred Stock, $0.001 par value, 10,000,000 shares authorized; none issued and outstanding as of June 30, 2024 and December 31, 2023 |
- |
- |
||||||
Common stock, $0.001 par value, 100,000,000 shares authorized; 5,939,516 and 4,617,798 shares issued and outstanding as of June 30, 2024 and December 31, 2023, respectively |
5,940 |
4,618 |
||||||
Additional paid-in capital |
10,134,801 |
4,045,024 |
||||||
Accumulated deficit |
(5,760,033) | (4,158,054) | ||||||
TOTAL STOCKHOLDERS' EQUITY (DEFICIT) |
4,380,708 |
(108,412) | ||||||
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT) |
$ |
5,456,937 |
$ |
1,099,202 |
2024年6月30日 |
2023 年 12 月 31 日 |
|||||||
(未經審計) |
||||||||
資產 |
||||||||
流動資產 |
||||||||
現金和現金等價物 |
$ |
4,740,006 |
$ |
525,500 |
||||
應收賬款 |
5,182 |
28,001 |
||||||
庫存,淨額 |
3,825 |
63,202 |
||||||
預付費用和其他流動資產 |
305,655 |
225 |
||||||
流動資產總額 |
5,054,668 |
616,928 |
||||||
財產和設備,淨額 |
206,816 |
235,292 |
||||||
經營租賃使用權資產 |
184,177 |
235,706 |
||||||
按金 |
11,276 |
11,276 |
||||||
總資產 |
$ |
5,456,937 |
$ |
1,099,202 |
||||
負債和股東權益(赤字) |
||||||||
流動負債 |
||||||||
應付賬款和應計費用 |
$ |
628,749 |
$ |
329,810 |
||||
客戶存款 |
4,150 |
3,425 |
||||||
經營租賃負債的流動部分 |
79,973 |
94,696 |
||||||
融資租賃負債的流動部分 |
2,010 |
- |
||||||
應付票據的當期部分,淨額 |
228,061 |
148,517 |
||||||
衍生責任 |
- |
238,000 |
||||||
流動負債總額 |
942,943 |
814,448 |
||||||
經營租賃負債,扣除流動部分 |
124,651 |
164,295 |
||||||
融資租賃負債,扣除流動部分 |
8,635 |
|||||||
應付票據,扣除流動部分 |
- |
228,871 |
||||||
負債總額 |
1,076,229 |
1,207,614 |
||||||
股東權益(赤字) |
||||||||
優先股,面值0.001美元,已獲授權1,000萬股;截至2024年6月30日和2023年12月31日,未發行和流通股票 |
- |
- |
||||||
普通股,面值0.001美元,授權1億股;截至2024年6月30日和2023年12月31日,已發行和流通的股票分別爲5,939,516和4,617,798股 |
5,940 |
4,618 |
||||||
額外的實收資本 |
10,134,801 |
4,045,024 |
||||||
累計赤字 |
(5,760,033) | (4,158,054) | ||||||
股東權益總額(赤字) |
4,380,708 |
(108,412) | ||||||
總負債和股東權益(赤字) |
$ |
5,456,937 |
$ |
1,099,202 |
KINDLY MD, INC.
CONDENSED STATEMENTS OF OPERATIONS
(UNAUDITED)
謝謝 MD, INC.
簡明的運營報表
(未經審計)
For the Three Months Ended
June 30,
|
For the Six Months Ended
June 30,
|
|||||||||||||||
2024 |
2023 |
2024 |
2023 |
|||||||||||||
Revenues |
$ |
639,057 |
$ |
979,538 |
$ |
1,468,086 |
$ |
2,139,883 |
||||||||
Operating Expenses |
||||||||||||||||
Cost of revenues |
61,947 |
59,508 |
69,691 |
108,132 |
||||||||||||
Salaries and wages |
1,126,893 |
1,109,559 |
1,834,859 |
2,042,860 |
||||||||||||
General and administrative |
461,677 |
385,536 |
787,222 |
743,719 |
||||||||||||
Depreciation |
25,733 |
26,224 |
50,634 |
51,666 |
||||||||||||
Total Operating Expenses |
1,676,250 |
1,580,827 |
2,742,406 |
2,946,377 |
||||||||||||
LOSS FROM OPERATIONS |
(1,037,193) | (601,289) | (1,274,320) | (806,494) | ||||||||||||
Other Income (Expenses) |
||||||||||||||||
Other income |
13,828 |
13,075 |
25,868 |
37,301 |
||||||||||||
Interest expense |
(318,450) | (8,194) | (375,689) | (8,194) | ||||||||||||
Loss on extinguishment of debt |
(38,889) | (38,889) | ||||||||||||||
Gain on change in fair value of derivative liability |
61,051 |
- |
61,051 |
- |
||||||||||||
Total Other Income (Expenses) |
(282,460) | 4,881 |
(327,659) | 29,107 |
||||||||||||
NET LOSS BEFORE INCOME TAXES |
(1,319,653) | (596,408) | (1,601,979) | (777,387) | ||||||||||||
INCOME TAX EXPENSE |
- |
- |
- |
- |
||||||||||||
NET LOSS |
$ |
(1,319,653) | $ |
(596,408) | $ |
(1,601,979) | $ |
(777,387) | ||||||||
LOSS PER COMMON SHARE - BASIC AND DILUTED |
$ |
(0.26) | $ |
(0.13) | $ |
(0.33) | $ |
(0.17) | ||||||||
WEIGHTED-AVERAGE NUMBER OF SHARES OUTSTANDING - BASIC AND DILUTED |
5,009,956 |
4,455,912 |
4,813,877 |
4,445,714 |
在已結束的三個月中
6月30日
|
在已結束的六個月中
6月30日
|
|||||||||||||||
2024 |
2023 |
2024 |
2023 |
|||||||||||||
收入 |
$ |
639,057 |
$ |
979,538 |
$ |
1,468,086 |
$ |
2,139,883 |
||||||||
運營費用 |
||||||||||||||||
收入成本 |
61,947 |
59,508 |
69,691 |
108,132 |
||||||||||||
薪金和工資 |
1,126,893 |
1,109,559 |
1,834,859 |
2,042,860 |
||||||||||||
一般和行政 |
461,677 |
385,536 |
787,222 |
743,719 |
||||||||||||
折舊 |
25,733 |
26,224 |
50,634 |
51,666 |
||||||||||||
總運營費用 |
1,676,250 |
1,580,827 |
2,742,406 |
2,946,377 |
||||||||||||
運營損失 |
(1,037,193) | (601,289) | (1,274,320) | (806,494) | ||||||||||||
其他收入(支出) |
||||||||||||||||
其他收入 |
13,828 |
13,075 |
25,868 |
37,301 |
||||||||||||
利息支出 |
(318,450) | (8,194) | (375,689) | (8,194) | ||||||||||||
債務消滅造成的損失 |
(38,889) | (38,889) | ||||||||||||||
衍生負債公允價值變動所得收益 |
61,051 |
- |
61,051 |
- |
||||||||||||
其他收入總額(支出) |
(282,460) | 4,881 |
(327,659) | 29,107 |
||||||||||||
所得稅前淨虧損 |
(1,319,653) | (596,408) | (1,601,979) | (777,387) | ||||||||||||
所得稅支出 |
- |
- |
- |
- |
||||||||||||
淨虧損 |
$ |
(1,319,653) | $ |
(596,408) | $ |
(1,601,979) | $ |
(777,387) | ||||||||
普通股每股虧損——基本虧損和攤薄虧損 |
$ |
(0.26) | $ |
(0.13) | $ |
(0.33) | $ |
(0.17) | ||||||||
已發行股票的加權平均數——基本股和攤薄股票 |
5,009,956 |
4,455,912 |
4,813,877 |
4,445,714 |
KINDLY MD, INC.
CONDENSED STATEMENTS OF CASH FLOWS
(UNAUDITED)
謝謝 MD, INC.
簡明的現金流量表
(未經審計)
For the Six Months Ended |
||||||||
2024 |
2023 |
|||||||
CASH FLOWS FROM OPERATING ACTIVITIES |
||||||||
Net loss |
$ |
(1,601,979) | $ |
(777,387) | ||||
Adjustments to reconcile loss to net cash used in operating activities: |
||||||||
Stock-based compensation |
15,500 |
338,021 |
||||||
Depreciation expense |
50,634 |
51,666 |
||||||
Loss on extinguishment of debt |
38,889 |
- |
||||||
Gain on change in fair value of derivative liability |
(61,051) | - |
||||||
Amortization of debt discounts |
357,439 |
876 |
||||||
Amortization of right-of-use assets |
51,529 |
61,589 |
||||||
Changes in operating assets and liabilities: |
||||||||
Accounts receivable |
22,819 |
4,161 |
||||||
Inventories |
59,377 |
(9,822) | ||||||
Prepaid expenses and other current assets |
(305,430) | 11,039 |
||||||
Security deposits |
- |
731 |
||||||
Accounts payable and accrued expenses |
298,939 |
106,668 |
||||||
Customer deposits |
725 |
300 |
||||||
Operating lease liabilities |
(54,367) | (62,806) | ||||||
Net cash used in operating activities |
(1,126,976) | (274,964) | ||||||
CASH FLOWS FROM INVESTING ACTIVITIES |
||||||||
Purchases of property and equipment |
(11,182) | (14,420) | ||||||
Net cash used in investing activities |
(11,182) | (14,420) | ||||||
CASH FLOWS FROM FINANCING ACTIVITIES |
||||||||
Net proceeds from issuance of notes payable |
45,000 |
- |
||||||
Net proceeds from issuance of related party note payable |
233,373 |
|||||||
Net proceeds from issuance of common shares and warrants in connection with a public offering |
5,860,650 |
- |
||||||
Repayments of related party note payable |
- |
(20,282) | ||||||
Repayments of notes payable |
(552,655) | - |
||||||
Repayments of finance lease liabilities |
(331) | - |
||||||
Net cash provided by financing activities |
5,352,664 |
213,091 |
||||||
NET CHANGE IN CASH AND CASH EQUIVALENTS |
4,214,506 |
(76,293) | ||||||
CASH AND CASH EQUIVALENTS |
||||||||
Beginning of the period |
525,500 |
186,918 |
||||||
End of the period |
$ |
4,740,006 |
$ |
110,625 |
||||
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION |
||||||||
Cash paid for interest |
$ |
19,089 |
$ |
- |
||||
Cash paid for income taxes |
$ |
- |
$ |
- |
||||
NON-CASH INVESTING AND FINANCING ACTIVITIES |
||||||||
Debt discounts on notes payable |
$ |
10,556 |
$ |
- |
||||
Debt discount on related party note payable |
$ |
- |
$ |
16,627 |
||||
Fair value of derivative liability recognized upon issuance of notes payable |
$ |
38,000 |
$ |
- |
||||
Extinguishment of derivative liability upon settlement of notes payable |
$ |
214,949 |
$ |
- |
||||
Finance purchases of property and equipment |
$ |
10,976 |
$ |
- |
在已結束的六個月中 |
||||||||
2024 |
2023 |
|||||||
來自經營活動的現金流 |
||||||||
淨虧損 |
$ |
(1,601,979) | $ |
(777,387) | ||||
爲將虧損與經營活動中使用的淨現金進行覈對而進行的調整: |
||||||||
基於股票的薪酬 |
15,500 |
338,021 |
||||||
折舊費用 |
50,634 |
51,666 |
||||||
債務消滅造成的損失 |
38,889 |
- |
||||||
衍生負債公允價值變動所得收益 |
(61,051) | - |
||||||
債務折扣的攤銷 |
357,439 |
876 |
||||||
使用權資產的攤銷 |
51,529 |
61,589 |
||||||
運營資產和負債的變化: |
||||||||
應收賬款 |
22,819 |
4,161 |
||||||
庫存 |
59,377 |
(9,822) | ||||||
預付費用和其他流動資產 |
(305,430) | 11,039 |
||||||
按金 |
- |
731 |
||||||
應付賬款和應計費用 |
298,939 |
106,668 |
||||||
客戶存款 |
725 |
300 |
||||||
經營租賃負債 |
(54,367) | (62,806) | ||||||
用於經營活動的淨現金 |
(1,126,976) | (274,964) | ||||||
來自投資活動的現金流 |
||||||||
購買財產和設備 |
(11,182) | (14,420) | ||||||
用於投資活動的淨現金 |
(11,182) | (14,420) | ||||||
來自融資活動的現金流量 |
||||||||
發行應付票據的淨收益 |
45,000 |
- |
||||||
發行關聯方應付票據的淨收益 |
233,373 |
|||||||
發行與公開發行相關的普通股和認股權證的淨收益 |
5,860,650 |
- |
||||||
關聯方應付票據的還款 |
- |
(20,282) | ||||||
應付票據的還款 |
(552,655) | - |
||||||
償還融資租賃負債 |
(331) | - |
||||||
融資活動提供的淨現金 |
5,352,664 |
213,091 |
||||||
現金和現金等價物的淨變化 |
4,214,506 |
(76,293) | ||||||
現金和現金等價物 |
||||||||
時期開始 |
525,500 |
186,918 |
||||||
期末 |
$ |
4,740,006 |
$ |
110,625 |
||||
現金流信息的補充披露 |
||||||||
支付利息的現金 |
$ |
19,089 |
$ |
- |
||||
爲所得稅支付的現金 |
$ |
- |
$ |
- |
||||
非現金投資和融資活動 |
||||||||
應付票據的債務折扣 |
$ |
10,556 |
$ |
- |
||||
關聯方應付票據的債務折扣 |
$ |
- |
$ |
16,627 |
||||
發行應付票據時確認的衍生負債的公允價值 |
$ |
38,000 |
$ |
- |
||||
應付票據結算後的衍生負債的消除 |
$ |
214,949 |
$ |
- |
||||
爲購買財產和設備提供資金 |
$ |
10,976 |
$ |
- |
SOURCE: KindlyMD, Inc
資料來源:KindlyMD, Inc